Case number 1:20-cv-01344
Allergan USA, Inc. et al v. Hetero Labs Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 20, 2021 | 82 | Stipulation of Dismissal (4) Docket Text: STIPULATION of Dismissal tween Plaintiffs and Defendants Hetero Labs Limited and Hetero USA, Inc., by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) Modified on 10/20/2021 (nms). |
| Oct 20, 2021 | 83 | Order (4) Docket Text: SO ORDERED Granting [82] Stipulation and Proposed Order (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 10/20/2021. (nms) |
| Oct 20, 2021 | 84 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,741,356 B2. (Attachments: # (1) Order)(nms) |
| Oct 20, 2021 | 84 | Order (4) |
| Oct 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [81] STIPULATION and Proposed Order to extend the deadline for the parties to exchange claim terms/phrases and their proposed constructions to October 22, 2021. Signed by Judge Richard G. Andrews on 10/19/2021. (nms) |
| Oct 19, 2021 | 81 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME the deadline for the parties to exchange claim terms/phrases and their proposed constructions to October 22, 2021 - filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) |
| Oct 6, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [80] STIPULATION and Proposed Order to Extend Time for claim construction deadlines. Signed by Judge Richard G. Andrews on 10/6/2021. (nms) |
| Oct 6, 2021 | 80 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Hetero Labs Limited, Hetero USA, Inc.. (Ormerod, Eve) Modified on 10/6/2021 (nms). |
| Sep 15, 2021 | 78 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order of Infringement of Claim 40 of the '356 Patent by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) |
| Sep 15, 2021 | 79 | Order (3) Docket Text: SO ORDERED Granting [78] Stipulation and Proposed Order of Infringement of Claim 40 of the '356 Patent. Signed by Judge Richard G. Andrews on 9/15/2021. (nms) |
| Aug 30, 2021 | 77 | Order (4) Docket Text: SO ORDERED Granting (D.I. 57 in 20-cv-1479-RGA; D.I. 76 in 19-cv-1674-RGA; D.I. 76 in 20-cv-1344-RGA) STIPULATION and Proposed Order to Extend Time (*Reset Deadlines/Hearings: Pretrial Order due by 10/11/2022, Status letter due by 7/6/2022, a Bench Trial is set to start 11/7/2022, at 8:30 AM in Courtroom 6A before Judge Richard G. Andrews, a Pretrial Conference is set for 10/21/2022, at 8:30 AM in Courtroom 6A) (see Order for further details). Signed by Judge Richard G. Andrews on 8/30/2021. Associated Cases: 1:19-cv-01674-RGA, 1:20-cv-01344-RGA, 1:20-cv-01479-RGA(nms) |
| Aug 27, 2021 | 76 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) Modified on 8/30/2021 (nms). Modified on 8/30/2021 (nms). |
| Aug 17, 2021 | 75 | Transcript (20) Docket Text: Official Transcript of Discovery Dispute Videoconference held on 08/04/21 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/7/2021. Redacted Transcript Deadline set for 9/17/2021. Release of Transcript Restriction set for 11/15/2021. (Triozzi, Heather) |
| Aug 4, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The letter filed at D.I. 70 has been removed from the docket. After reviewing the filing it was determined that it was a redacted version of a previous sealed filing. Defendants are directed to refile the redacted letter using the redacted document filing code thereby allowing a link to the sealed filing to be established. (nms) |
| Aug 4, 2021 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Discovery Conference held on 8/4/2021. Counsel for Plaintiffs: S. Simonetti. Counsel for Defendants: E. Ormerod. Counsel shall confer on a claim construction hearing date. The transcript shall serve as the Court's memorialization of the hearing. (Court Reporter Heather Triozzi.) (lak) |
| Aug 4, 2021 | 72 | Main Document (5) Docket Text: REDACTED VERSION of [65] Letter, by Hetero Labs Limited, Hetero USA, Inc.. (Attachments: # (1) Proposed Order, # (2) Exhibits 1-6)(Ormerod, Eve) Modified on 8/4/2021 (nms). |
| Aug 4, 2021 | 72 | Proposed Order (2) |
| Aug 4, 2021 | 72 | Exhibits 1-6 (186) |
| Aug 4, 2021 | 73 | Main Document (5) Docket Text: REDACTED VERSION of [68] Letter, by Hetero Labs Limited, Hetero USA, Inc.. (Attachments: # (1) Exhibits 7-12)(Ormerod, Eve) Modified on 8/4/2021 (nms). |
| Aug 4, 2021 | 73 | Exhibits 7-12 (31) |
| Aug 4, 2021 | 74 | Main Document (5) Docket Text: REDACTED VERSION of [66] Letter by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Attachments: # (1) Exhibits A-B)(Tigan, Jeremy) |
| Aug 4, 2021 | 74 | Exhibits A-B (3) |
| Aug 3, 2021 | N/A | Remark (0) Docket Text: Remark: The public may access the hearing scheduled for 8/4/2021, at 11:00 a.m. by dialing the following phone number: +1 202-503-1666, then enter Conference ID: 742633077#. The dial-in information provides listening capabilities only. (lak) |
| Jul 30, 2021 | 71 | Main Document (5) Docket Text: REDACTED VERSION of [64] Letter, by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A-G)(Tigan, Jeremy) |
| Jul 30, 2021 | 71 | Text of Proposed Order (1) |
| Jul 30, 2021 | 71 | Exhibit A-G (64) |
| Jul 28, 2021 | 67 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants Hetero Labs Ltd. and Hetero USA, Inc.'s Second Set of Requests for Admissions (Nos. 2-29) and (2) Plaintiffs' Objections and Responses to Defendants Hetero Labs Ltd. and Hetero USA, Inc.'s Third Set of Interrogatories (No. 9) filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy) |
| Jul 28, 2021 | 69 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Objections and Responses to Plaintiffs' First Set of Requests for Admissions (Nos. 1-2) and 2) Objections and Responses to Plaintiffs' Second Set of Interrogatories (Nos. 2-3) filed by Hetero Labs Limited, Hetero USA, Inc..(Ormerod, Eve) |
| Jul 21, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Carolyn S. Wall, Mark A. Hayden, Hassen Sayeed, James Y. Li, and Daniel O'Boyle for Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., and for Janssen Pharmaceutica NV added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Jul 21, 2021 | 62 | Stipulation (3) Docket Text: Authenticity Stipulation and [Proposed] Order, by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) Modified on 7/21/2021 (nms). |
| Jul 21, 2021 | 63 | Order (3) Docket Text: SO ORDERED Granting [62] Authenticity Stipulation and Proposed Order. Signed by Judge Richard G. Andrews on 7/21/2021. (nms) |
| Jul 16, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The parties have advised that discovery disputes have arisen that require judicial attention. The Court will hold a discovery conference on 8/4/2021, at 11:00 AM. In preparation for this conference the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Scheduling Order. The conference will be held using Teams. A joint email with the email addresses for all those participating in the conference shall be due to the Court's Case Manager by 4:00 PM on 7/27/2021. Ordered by Judge Richard G. Andrews on 7/16/2021. (nms) |
| Jul 15, 2021 | 60 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Second Amended Invalidity Contentions filed by Hetero Labs Limited, Hetero USA, Inc..(Ormerod, Eve) |
| Jul 12, 2021 | 59 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Supplemental Response to Defendants Hetero Labs Ltd. and Hetero USA, Inc.'s First Set of Interrogatories (Nos. 1-7) filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy) |
| Jun 28, 2021 | 57 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests for Admissions to Hetero Labs Limited and Hetero USA, Inc. (Nos. 1-2), and (2) Plaintiffs' Second Set of Interrogatories to Hetero Labs Limited and Hetero USA, Inc. (Nos. 2-3) filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy) |
| Jun 28, 2021 | 58 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Third Set of Interrogatories to Plaintiffs (No. 9); 2) Second Set of Requests for Admission to Plaintiffs (No. 2-29) and 3) First Amended Invalidity Contentions filed by Hetero Labs Limited, Hetero USA, Inc..(Ormerod, Eve) |
| Jun 25, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [56] STIPULATION TO EXTEND TIME Defendants' Final Invalidity Contentions to July 15, 2021. Signed by Judge Richard G. Andrews on 6/25/2021. (nms) |
| Jun 25, 2021 | 56 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Defendants' Final Invalidity Contentions to July 15, 2021 - filed by Hetero Labs Limited, Hetero USA, Inc.. (Ormerod, Eve) |
| Jun 24, 2021 | 55 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy) |
| Jun 14, 2021 | 53 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) and 2) Objections and Responses to Plaintiff's First Set of Interrogatories filed by Hetero Labs Limited, Hetero USA, Inc..(Belgam, Neal) |
| Jun 14, 2021 | 54 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants Hetero Labs Ltd. and Hetero USA, Inc.'s Notice of Rule 30(b)(6) Deposition of Plaintiffs filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy) |
| Jun 7, 2021 | 52 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants Hetero Labs Ltd. and Hetero USA, Inc.'s Second Set of Interrogatories (No. 8) filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy) |
| Jun 1, 2021 | 45 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Chaozhong Cai on June 30, 2021 at 9:30 a.m. EDT filed by Hetero Labs Limited, Hetero USA, Inc..(Ormerod, Eve) |
| Jun 1, 2021 | 46 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Craig Diamond on June 22, 2021 at 9:30 a.m. EDT filed by Hetero Labs Limited, Hetero USA, Inc..(Ormerod, Eve) |
| Jun 1, 2021 | 47 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Wei He on June 24, 2021 at 9:30 a.m. EDT filed by Hetero Labs Limited, Hetero USA, Inc..(Ormerod, Eve) |
| Jun 1, 2021 | 48 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Robert W. Kavash on July 7, 2021 at 9:30 a.m. EDT filed by Hetero Labs Limited, Hetero USA, Inc..(Ormerod, Eve) |
| Jun 1, 2021 | 49 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Henry J. Breslin on July 15, 2021 at 9:30 a.m. EDT filed by Hetero Labs Limited, Hetero USA, Inc..(Ormerod, Eve) |
| Jun 1, 2021 | 50 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Pamela Hornby on June 17, 2021 at 9:30 a.m. EDT filed by Hetero Labs Limited, Hetero USA, Inc..(Ormerod, Eve) |
| Jun 1, 2021 | 51 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Notice to Hetero Labs Limited and Hetero USA, Inc. of Depositions Pursuant to Federal Rule of Civil Procedure 30(b)(1) and (2) Plaintiffs' Notice of the Deposition of Hetero Labs Limited and Hetero USA, Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy) |
| May 27, 2021 | 44 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Allergan USA, Inc., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, and Janssen Pharmaceutica NV on to be determined filed by Hetero Labs Limited, Hetero USA, Inc..(Ormerod, Eve) |
| May 17, 2021 | 43 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Set of Interrogatories to Hetero Labs Limited and Hetero USA, Inc. (No. 1) and (2) Plaintiffs' First Supplemental Response to Defendants Hetero Labs Ltd. and Hetero USA, Inc.'s First Set of Interrogatories (Nos. 1-7) filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy) |
| Apr 27, 2021 | 42 | Notice of Change of Address (1) Docket Text: NOTICE of Change of Address by Eve H. Ormerod (Ormerod, Eve) |
| Apr 14, 2021 | 41 | Notice (Other) (7) Docket Text: NOTICE of Withdrawal of Counsel by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV, Allergan Holdings Unlimited Company, Allergan USA, Inc., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV (Tigan, Jeremy) |
| Apr 5, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (154 in 19-cv-1727-RGA; 33 in 20-cv-1479-RGA; 38 in 20-cv-1344-RGA) MOTION for Pro Hac Vice Appearance of Attorney Hassen Sayeed, Daniel O'Boyle, Carolyn Wall, James Yi Li and Mark A. Hayden of O'Melveny & Myers LLP, filed by Janssen Pharmaceutica NV, Allergan Pharmaceuticals International Limited, Eden Biodesign, LLC., Allergan USA, Inc., Allergan Holdings Unlimited Company. Signed by Judge Richard G. Andrews on 4/5/2021. Associated Cases: 1:19-cv-01727-RGA, 1:20-cv-01344-RGA, 1:20-cv-01479-RGA(nms) |
| Apr 5, 2021 | 40 | Order (5) Docket Text: SO ORDERED as modified re (D.I. 31 in 20-cv-1479-RGA; D.I. 36 in 20-cv-1344-RGA; D.I. 152 in 19-cv-1727-RGA) Stipulation and Proposed Order to Modify Case Schedules. Signed by Judge Richard G. Andrews on 4/5/2021. Associated Cases: 1:19-cv-01674-RGA, 1:19-cv-01727-RGA, 1:20-cv-01344-RGA, 1:20-cv-01479-RGA(nms) |
| Apr 2, 2021 | 37 | Notice Requesting Removal of Co-Counsel (7) Docket Text: NOTICE requesting Clerk to remove Amanda K. Antons as co-counsel. Reason for request: No Longer with Firm. (Tigan, Jeremy) |
| Apr 2, 2021 | 38 | Motion for Leave to Appear Pro Hac Vice (12) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Hassen Sayeed, Daniel O'Boyle, Carolyn Wall, James Yi Li and Mark A. Hayden of O'Melveny & Myers LLP - filed by Eden Biodesign, LLC., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) |
| Apr 2, 2021 | 39 | Notice (Other) (6) Docket Text: NOTICE of Appearance of Lisa B. Pensabene of O'Melveny & Myers LLP by Eden Biodesign, LLC., Allergan Holdings Unlimited Company, Allergan USA, Inc., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV (Tigan, Jeremy) |
| Mar 31, 2021 | 36 | Stipulation (5) Docket Text: STIPULATION and [Proposed] Order to Modify Case Schedules by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV, Allergan Holdings Unlimited Company, Allergan USA, Inc., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy) |
| Mar 16, 2021 | 35 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Identification of Prior Art References and Combinations filed by Hetero Labs Limited, Hetero USA, Inc..(Ormerod, Eve) |
| Feb 26, 2021 | 34 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants Hetero Labs Ltd. and Hetero USA, Inc.'s First Set of Interrogatories (Nos. 1-7), (2) Plaintiffs' Objections and Responses to Defendants Hetero Labs Ltd. and Hetero USA, Inc.'s First Set of Requests for Admission to Plaintiffs (No. 1) and (3) Plaintiffs' Objections and Responses to Defendants Hetero Labs Ltd. and Hetero USA, Inc.'s First Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 1-55) filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy) |
| Feb 10, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 26 in 20-cv-1479-RGA; D.I. 33 in 20-cv-1344-RGA) MOTION for Pro Hac Vice Appearance of Attorney Peter J. Armenio, Colleen Tracy James, Allyson E. Parks and Amanda K. Antons, filed by Janssen Pharmaceutica NV, Allergan Holdings Unlimited Company, Janssen Pharmaceutica NV, Allergan USA, Inc., Allergan USA, Inc., Allergan Pharmaceuticals International Limited, Allergan Pharmaceuticals International Limited, Allergan Holdings Unlimited Company. Signed by Judge Richard G. Andrews on 2/10/2021. Associated Cases: 1:20-cv-01344-RGA, 1:20-cv-01479-RGA(nms) |
| Feb 10, 2021 | 33 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Peter J. Armenio, Colleen Tracy James, Allyson E. Parks and Amanda K. Antons - filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV, Allergan Holdings Unlimited Company, Allergan USA, Inc., Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Tigan, Jeremy) |
| Jan 26, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Markman hearing set for 5/5/2021, is CANCELED per the parties request (D.I. [30]). Ordered by Judge Richard G. Andrews on 1/26/2021. (nms) |
| Jan 26, 2021 | 32 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) First Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 1-55); 2) First Set of Interrogatories to Plaintiffs (Nos. 1-7); and 3) First Set of Requests for Admission to Plaintiffs (No. 1) filed by Hetero Labs Limited, Hetero USA, Inc..(Ormerod, Eve) |
| Jan 25, 2021 | 30 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews, from Jeremy A. Tigan, regarding claim construction briefing and hearing. (Tigan, Jeremy) Modified on 1/26/2021 (nms). |
| Jan 21, 2021 | 29 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Invalidity Contentions and Accompanying Document Production filed by Hetero Labs Limited, Hetero USA, Inc..(Belgam, Neal) |
| Jan 20, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [28] STIPULATION TO EXTEND TIME to provide 1) Defendants' Initial Invalidity Contentions and 2) for the Parties to Exchange Lists of Claim Terms and Proposed Constructions to 1) January 20, 2021 and 2) January 26, 2021. Signed by Judge Richard G. Andrews on 1/20/2021. (nms) |
| Jan 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [27] STIPULATION TO EXTEND TIME for Defendants' Initial Invalidity Contentions to January 19, 2021. Signed by Judge Richard G. Andrews on 1/19/2021. (nms) |
| Jan 19, 2021 | 28 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to provide 1) Defendants' Initial Invalidity Contentions and 2) for the Parties to Exchange Lists of Claim Terms and Proposed Constructions to 1) January 20, 2021 and 2) January 26, 2021 - filed by Hetero Labs Limited, Hetero USA, Inc.. (Belgam, Neal) |
| Jan 15, 2021 | 27 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants' Initial Invalidity Contentions to January 19, 2021 - filed by Hetero Labs Limited, Hetero USA, Inc.. (Ormerod, Eve) |
| Jan 6, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: As a result of the teleconference on 12/8/20, a teleconference has been scheduled for Monday, 2/8/21 at 10:30 a.m. Eastern. This matter will be discussed along with 19-1727 also scheduled on the same date and time. Signed by Judge Mary Pat Thynge on 1/6/21. (kjk) |
| Dec 18, 2020 | 23 | Proposed Order (30) Docket Text: PROPOSED Protective Order, by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) Modified on 12/18/2020 (nms). |
| Dec 18, 2020 | 24 | Order (30) Docket Text: SO ORDERED Granting [23] Proposed Stipulated Protective Order. Signed by Judge Richard G. Andrews on 12/18/2020. (nms) |
| Dec 18, 2020 | 25 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts Relating Each Accused Product to the Asserted Claims filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy) |
| Dec 11, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [22] STIPULATION TO EXTEND TIME to Submit Proposed Protective Order and Serve Initial Infringement Contentions to December 18, 2020. Signed by Judge Richard G. Andrews on 12/11/2020. (nms) |
| Dec 11, 2020 | 22 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Submit Proposed Protective Order and Serve Initial Infringement Contentions to December 18, 2020 - filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) |
| Dec 4, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [21] STIPULATION and Proposed Order to Extend Time to submit Proposed Protective Order to December 11, 2020. Signed by Judge Richard G. Andrews on 12/4/2020. (nms) |
| Dec 4, 2020 | 21 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to December 11, 2020 - filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) |
| Nov 20, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [20] STIPULATION and Proposed Order to extend time to Submit Proposed Protective Order to December 4, 2020. Signed by Judge Richard G. Andrews on 11/20/2020. (nms) |
| Nov 20, 2020 | 20 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Submit Proposed Protective Order to December 4, 2020 - filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) |
| Nov 13, 2020 | 18 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1), (2) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, and (3) Plaintiffs' Initial Paragraph 4(a) Disclosures filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV.(Tigan, Jeremy) |
| Nov 13, 2020 | 19 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Rule 26(a) Initial Disclosures and Paragraph 3 Disclosures filed by Hetero Labs Limited, Hetero USA, Inc..(Ormerod, Eve) |
| Nov 2, 2020 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak) |
| Nov 2, 2020 | 14 | Proposed Order (14) Docket Text: PROPOSED Scheduling Order, by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (Tigan, Jeremy) Modified on 11/2/2020 (nms). |
| Nov 2, 2020 | 15 | Scheduling Order (14) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/12/2021. Amended Pleadings due by 3/12/2021. Fact Discovery completed by 5/14/2021. A Status Conference is set for 1/7/2022, at 9:00 AM in Courtroom 6A. Joint Claim Construction Brief due by 4/9/2021. A Markman Hearing is set for 5/5/2021, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 4/15/2022, at 9:00 AM in Courtroom 6A. A Bench Trial is set to start 5/2/2022, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 11/2/2020. (nms) |
| Nov 2, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Rule 16(b) Conference set for 11/4/2020, is CANCELED. Ordered by Judge Richard G. Andrews on 11/2/2020. (nms) |
| Nov 2, 2020 | 17 | Order Setting Teleconference (4) Docket Text: ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 12/18/2020 at 11:30 AM Eastern Time with Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 11/2/20. (cak) |
| Oct 15, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Dmitry V. Shelhoff,Edward D. Pergament,Kenneth S. Canfield for Hetero Labs Limited and Hetero USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Oct 15, 2020 | 12 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 11/4/2020, at 2:00 PM (see Order for further details). Signed by Judge Richard G. Andrews on 10/15/2020. (nms) |
| Oct 15, 2020 | 13 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews, from Jeremy A. Tigan, regarding dial-in number for scheduling conference on November 4, 2020. (Tigan, Jeremy) Modified on 10/16/2020 (nms). |
| Oct 12, 2020 | 10 | Answer to Complaint (7) Docket Text: ANSWER to [1] Complaint, and Additional Defenses by Hetero Labs Limited, Hetero USA, Inc..(Belgam, Neal) Modified on 10/13/2020 (nms). |
| Oct 12, 2020 | 11 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hetero Labs, Ltd., Corporate Parent Hetero Drugs Ltd. for Hetero USA, Inc. filed by Hetero Labs Limited, Hetero USA, Inc.. (Belgam, Neal) |
| Oct 9, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff, Edward D. Pergament, and Kenneth S. Canfield, filed by Hetero Labs Limited, Hetero USA, Inc.. Signed by Judge Richard G. Andrews on 10/9/2020. (nms) |
| Oct 9, 2020 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. Hetero USA, Inc. served on 10/7/2020, answer due 10/28/2020. (Tigan, Jeremy) |
| Oct 9, 2020 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. Hetero Labs Limited served on 10/7/2020, answer due 10/28/2020. (Tigan, Jeremy) |
| Oct 9, 2020 | 9 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff, Edward D. Pergament, and Kenneth S. Canfield - filed by Hetero Labs Limited, Hetero USA, Inc.. (Ormerod, Eve) |
| Oct 7, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Oct 2, 2020 | 1 | Main Document (8) Docket Text: COMPLAINT filed against Hetero Labs Limited, Hetero USA, Inc. - Magistrate Consent Notice to Pltf. (Filing fee $400, receipt number ADEDC-3241437.) - filed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Janssen Pharmaceutica NV. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(kmd) (Attachment 2 replaced on 10/5/2020) (kmd). |
| Oct 2, 2020 | 1 | Exhibit A (78) |
| Oct 2, 2020 | 1 | Civil Cover Sheet (1) |
| Oct 2, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
| Oct 2, 2020 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: n/a. Date of Expiration of Patent: 5/27/2029.Thirty Month Stay Deadline: 4/2/2023. (kmd) |
| Oct 2, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,741,356 B2. (kmd) |
| Oct 2, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceutica NV; Corporate Parent Abbvie, Inc. for Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc. - filed by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals International Limited, Allergan USA, Inc., Janssen Pharmaceutica NV. (kmd) |
| Oct 2, 2020 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (kmd) |
| Oct 2, 2020 | 1 | Complaint* (1) |
